Conference Paper: ALTERNATIVE (EGF 114299): a study of lapatinib, trastuzumab, endocrine therapy in patients who received neo/adjuvant trastuzumab and endocrine therapy.
| Title | ALTERNATIVE (EGF 114299): a study of lapatinib, trastuzumab, endocrine therapy in patients who received neo/adjuvant trastuzumab and endocrine therapy. |
|---|---|
| Authors | Gradishar, W Kahan, Z Tsang, JWH Timcheva, C Tjulandin, S Cardoso, F Grigiene, R Iwata, H Keane, M Luebbe, K Neskovic-Konstantinovic, Z Simon, S Stemmer, SM Vrbanec, D Arbani, T Florance, A Huang, Y Leigh, M Wroblewski, S Johnston, S |
| Issue Date | 2012 |
| Citation | American Society of Clinical Oncology Annual Meeting 2012 [How to Cite?] |
| dc.contributor.author | Gradishar, W |
|---|---|
| dc.contributor.author | Kahan, Z |
| dc.contributor.author | Tsang, JWH |
| dc.contributor.author | Timcheva, C |
| dc.contributor.author | Tjulandin, S |
| dc.contributor.author | Cardoso, F |
| dc.contributor.author | Grigiene, R |
| dc.contributor.author | Iwata, H |
| dc.contributor.author | Keane, M |
| dc.contributor.author | Luebbe, K |
| dc.contributor.author | Neskovic-Konstantinovic, Z |
| dc.contributor.author | Simon, S |
| dc.contributor.author | Stemmer, SM |
| dc.contributor.author | Vrbanec, D |
| dc.contributor.author | Arbani, T |
| dc.contributor.author | Florance, A |
| dc.contributor.author | Huang, Y |
| dc.contributor.author | Leigh, M |
| dc.contributor.author | Wroblewski, S |
| dc.contributor.author | Johnston, S |
| dc.date.accessioned | 2012-09-20T08:20:48Z |
| dc.date.available | 2012-09-20T08:20:48Z |
| dc.date.issued | 2012 |
| dc.identifier.citation | American Society of Clinical Oncology Annual Meeting 2012 [How to Cite?] |
| dc.identifier.hkuros | 210741 |
| dc.identifier.uri | http://hdl.handle.net/10722/165601 |
| dc.language | eng |
| dc.relation.ispartof | American Society of Clinical Oncology Annual Meeting 2012 |
| dc.title | ALTERNATIVE (EGF 114299): a study of lapatinib, trastuzumab, endocrine therapy in patients who received neo/adjuvant trastuzumab and endocrine therapy. |
| dc.type | Conference_Paper |

